Product
Placebo Comparator 1
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
An Investigator Initiated Clinical Study To Evaluate the Efficacy and Safety of HH-120 Nasal Spray as Post Exposure Prophylaxis (PEP) Regimen in Adult Close Contacts of Individuals Infected With SARS-CoV-2Status: Completed, Estimated PCD: 2022-12-06